retatrutide phase 3 trials Looking forward to when #retatrutide's trial results will become available. There are are 4 planned TRIUMPH investigating Retatrutide Shows 28% Weight Loss

A five-year study demonstrated that weekly Wegovy injections reduced the overall risk of heart attack, stroke, and cardiovascular death by 20%

Nocturnal hypoglycaemia may occur when Ozempic is used in combination with sulphonylureas or insulin

It's a popular skin-care treatment for dark spots, but, according to Purvisha Patel, MD, a board-certified dermatologist based in Memphis, Tennessee, and founder of Visha Skincare, its main purpose in medical practice stems from its blood-clotting properties

By encapsulating GHK-Cu in liposomes, this formulation protects the active ingredient and delivers it directly into cells

Although combined therapy is still not common practice because of the relatively recent regulatory approval, these studies highlight the potential of dual GLP-1 RA + SGLT2i therapy to synergistically reduce cardiovascular disease and decelerate renal decompensation [75]

Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function